推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

Anti-Cancer Agents in Medicinal Chemistry

2023年12月最新中科院分区表数据已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 ANTI-CANCER AGE最新评论:期刊主页网址: http://benthamscience.com/cmcaca/ (2012-02-05)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

按研究方向查看:


Anti-Cancer Agents in Medicinal Chemistry期刊基本信息Hello,您是该期刊的第36691位访客

基本信息 登录收藏
期刊名字Anti-Cancer Agents in Medicinal ChemistryAnti-Cancer Agents in Medicinal Chemistry

ANTI-CANCER AGENT ME
(此期刊被最新的JCR期刊SCIE收录)

LetPub评分
5.3
50人评分
我要评分

声誉
6.4

影响力
4.1

速度
7.0

期刊ISSN1871-5206
微信扫码收藏此期刊
E-ISSN1875-5992
2022-2023最新影响因子
(数据来源于搜索引擎)
2.8 点击查看影响因子趋势图
实时影响因子 截止2023年12月27日:2.183
2022-2023自引率3.60%点击查看自引率趋势图
五年影响因子2.7
h-index 82
CiteScore
CiteScoreSJRSNIPCiteScore排名
4.300.4280.654
学科分区排名百分位
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Pharmacology
Q3157 / 301
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Molecular Medicine
Q3111 / 171
大类:Pharmacology, Toxicology and Pharmaceutics
小类:Cancer Research
Q3141 / 214

期刊简介Formerly: Current Medicinal Chemistry - Anti-Cancer Agents.
Anti-Cancer Agents in Medicinal Chemistry aims to cover all the latest and outstanding developments in medicinal chemistry and rational drug design for the discovery of anti-cancer agents.

Each issue contains a series of timely in-depth reviews and guest edited issues written by leaders in the field covering a range of current topics in cancer medicinal chemistry. The journal only considers high quality research papers for publication.

Anti-Cancer Agents in Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments in cancer drug discovery.
期刊官方网站http://benthamscience.com/cmcaca/
期刊投稿网址http://benthamscience.com/cmcaca/MSandI.htm
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足Anti-Cancer Agents in Medicinal Chemistry的语言要求,还能让Anti-Cancer Agents in Medicinal Chemistry编辑和审稿人得到更好的审稿体验,让稿件最大限度地被Anti-Cancer Agents in Medicinal Chemistry编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式BENTHAM SCIENCE PUBL LTD, EXECUTIVE STE Y26, PO BOX 7917, SAIF ZONE, SHARJAH, U ARAB EMIRATES, 1200 BR
出版商Bentham Science Publishers B.V.
涉及的研究方向ONCOLOGY-CHEMISTRY, MEDICINAL
出版国家或地区U ARAB EMIRATES
出版语言English
出版周期Monthly
出版年份2006
年文章数 276点击查看年文章数趋势图
Gold OA文章占比1.14%
研究类文章占比:
文章 ÷(文章 + 综述)
63.41%
WOS期刊SCI分区
2022-2023年最新版
WOS分区等级:3区

按学科分区JIF分区JIF排名JIF百分位
学科:CHEMISTRY, MEDICINAL
类别:SCIE
Q340/60
学科:ONCOLOGY
类别:SCIE
Q3168/241
中科院《国际期刊预警
名单(试行)》名单
2024年02月发布的2024版:不在预警名单中

2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2020年12月发布的2020版:不在预警名单中
中科院SCI期刊分区
2023年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 2区4区1区
CHEMISTRY, MEDICINAL
药物化学
1区4区4区
ONCOLOGY
肿瘤学
4区3区4区
中科院SCI期刊分区
2022年12月升级版
大类学科小类学科Top期刊综述期刊
医学 3区4区3区
CHEMISTRY, MEDICINAL
药物化学
1区3区4区
ONCOLOGY
肿瘤学
1区1区4区
中科院SCI期刊分区
2021年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 3区4区1区
CHEMISTRY, MEDICINAL
药物化学
2区3区4区
ONCOLOGY
肿瘤学
1区1区4区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1871-5206%5BISSN%5D
平均审稿速度网友分享经验:
偏慢,4-8周
平均录用比例网友分享经验:
较易
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在Anti-Cancer Agents in Medicinal Chemistry顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 Anti-Cancer Agents in Medicinal Chemistry期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 Anti-Cancer Agents in Medicinal Chemistry中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
Anti-Cancer Agents in Medicinal Chemistry上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    ACS Chemical Neuroscience549.10
    Nucleic Acid Therapeutics617.20
    MedChemComm444.70
    ACS Combinatorial Science787.50
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE592385
    BIOMATERIALS506291
    Journal of Materials Chemistry B453120
    BIOMEDICINE & PHARMACOTHERAPY452341
    Frontiers in Pharmacology440764
    Frontiers in Immunology410626
    COLLOIDS AND SURFACES B-BIOINTERFACES398590
    JOURNAL OF ETHNOPHARMACOLOGY396777
    Frontiers in Oncology376707
    Acta Biomaterialia369311
  •  

    Anti-Cancer Agents in Medicinal Chemistry Anti-Cancer Agents in Medicinal Chemistry
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.Alantolactone Inhibits Melanoma Cell Culture Viability and Migration and Promotes Apoptosis by Inhibiting Wnt/beta-Catenin Signaling

    Author: Zhang, Lingzhao; Chen, Jiayi; Chen, Yangmei; Zou, Daopei; Pu, Yihuan; Wei, Mengqi; Huang, Yanran; Li, Yuxin; Huang, Qing; Chen, Jin
    Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 1, pp. 94-104. DOI: 10.2174/1871520622666220519100054
        PubMed      DOI
    2.Novel Potent EGFR-JAK3 Dual-Target Inhibitor that Overcomes KRAS Mutation Resistance in Colorectal Cancer

    Author: Wu, Tingyu; Yu, Jiawen; Wang, Changyuan; Jin, Yue; Zheng, Xu; Chen, Lixue; Ma, Xiaodong; Sun, Xiuli
    Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 4, pp. 440-449. DOI: 10.2174/1871520622666220609112816
        PubMed      DOI
    3.Advances in the Study of Hexokinase 2 (HK2) Inhibitors

    Author: Wang, Shaopei; Zhuang, Yan; Xu, Jindan; Tong, Yan; Li, Xiaofei; Dong, Chunhong
    Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 7, pp. 736-746. DOI: 10.2174/1871520623666221020092423
        PubMed      DOI
    4.Molecular Mechanisms of Sanguinarine in Cancer Prevention and Treatment

    Author: Ullah, Asmat; Ullah, Najeeb; Nawaz, Touseef; Aziz, Tariq
    Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 7, pp. 765-778. DOI: 10.2174/1871520622666220831124321
        PubMed      DOI
    5.The Synergistic Anti-colon Cancer Effect of Aurora A Inhibitors and AKT Inhibitors Through PI3K/AKT Pathway

    Author: Sun, Cheng; Qu, Zhen; Liu, Weilin; Qiu, Zhigang; Lu, Yanfeng; Sun, Zhenqing
    Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 1, pp. 87-93. DOI: 10.2174/1871520622666220422133537
        PubMed      DOI
    6.Ganoderic Acid A Enhances Tumor Suppression Function of Oxaliplatin via Inducing the Cytotoxicity of T Cells

    Author: Song, Zhichao; Wang, Chunhui; Ding, Fei; Zou, Hao; Liu, Chengkui
    Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 7, pp. 832-838. DOI: 10.2174/1871520623666221103110934
        PubMed      DOI
    7.Isoproterenol-induced Upregulation of HPSE Accelerates Triple-negative Breast Cancer Cell Proliferation and Migration through Enhancing the Transcriptional Activity of HIF-1 alpha

    Author: Qiu, Jian; Shen, Zhongyi; Jiang, Guoqin; Ni, Qichao
    Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 4, pp. 470-477. DOI: 10.2174/1871520622666220817125817
        PubMed      DOI
    8.Tanshinone IIA Alleviates the Biological Characteristics of Colorectal Cancer via Activating the ROS/JNK Signaling Pathway

    Author: Qian, Jun; Cao, Yi; Zhang, Junfeng; Li, Lingchang; Wu, Juan; Yu, Jialin; Huo, Jiege
    Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 2, pp. 227-236. DOI: 10.2174/1871520622666220421093430
        PubMed      DOI
    9.Combined Effects of Programmed Cell Death-1 Blockade and Endostar on Brain Metastases of Lung Cancer

    Author: Qi, Xuejiao; Zhao, Yinlong; Yang, Song; Sun, YuMeng; Liu, Honglei; Liu, Pengyu; Feng, Shiyao; Tui, Hongbo; Yuan, Zheng; Yang, Jiankai; Bu, Hui
    Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 6, pp. 709-716. DOI: 10.2174/1871520622666220827125929
        PubMed      DOI
    10.New neo-Clerodane Diterpenoids Isolated from Ajuga decumbens Thunb., Planted at Pingtan Island of Fujian Province with the Potent Anticancer Activity

    Author: Olatunde, Olagoke Zacchaeus; Yong, Jianping; Lu, Canzhong
    Journal: ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY. 2023; Vol. 23, Issue 2, pp. 237-244. DOI: 10.2174/1871520622666220620151225
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144642.90
    LANCET700133.20
    NEW ENGLAND JOURNAL OF MEDICINE933134.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62245.40
    NATURE REVIEWS DRUG DISCOVERY289123.80
    BMJ-British Medical Journal015.30
    BMJ-British Medical Journal015.30
    NATURE REVIEWS IMMUNOLOGY35183.00
    NATURE MEDICINE497107.50
    Nature Reviews Disease Primers4860.90
    同分区等级的其他期刊名称 h-index CiteScore
    HARVARD BUSINESS REVIEW02.40
    QJM-AN INTERNATIONAL JOURNAL OF MEDICINE1086.10
    Energy Material Advances08.50
    CLINICAL AND EXPERIMENTAL HYPERTENSION453.60
    Journal of Public Transportation07.00
    Asian Journal of Psychiatry010.90
    Chinese Journal of Population Resources and Environment02.60
    VIEW08.60
    HLA933.00
    INTERNATIONAL JOURNAL OF SOCIAL PSYCHIATRY011.50


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共1条 (包含回复)

我来分享

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2024 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦1803室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451